Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7223397 Potentiation of anti-CD38-Immunotoxin cytotoxicity

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
January 7, 1999
Date of Patent
May 29, 2007
Patent Application Number
09226895
Patent Citations Received
‌
US Patent 12091466 Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
3
‌
US Patent 11713355 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
4
‌
US Patent 11939395 Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38
5
‌
US Patent 12060432 Combination therapies with anti-CD38 antibodies
6
‌
US Patent 11708420 Subcutaneous formulations of anti-CD38 antibodies and their uses
7
‌
US Patent 11708419 Subcutaneous formulations of anti-CD38 antibodies and their uses
8
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7223397
Patent Primary Examiner
‌
Karen A. Canella
Industry
Request Data

Find more entities like US Patent 7223397 Potentiation of anti-CD38-Immunotoxin cytotoxicity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo